InsidersTradesSigma
Discover the full record of transactions filed by DOUGLAS FALLER, Executive. Insider active across 4 companies, notably Oryzon Genomics, S.A.. In total, 2 reports have been logged. History available since 9 February 2023. The latest transaction was disclosed on 6 February 2024 (Other). Regulator: CNMV. All data is accessible without signup.
2 of 2 declarations
Douglas Faller is the Chief Medical Officer at Oryzon Genomics, S.A. He is responsible for medical strategy and overseeing clinical operations, contributing to innovation in the biopharmaceutical sector.